Cell-viability assays of honeybee venom and melittin in murine breast cancer and normal cell lines confirmed enhanced selectivity for aggressive murine tumor cell lines, such as the p53-mutant claudin-low T11 and the BRCA-mutant B.1537,38 (Supplementary Fig. 1). This evidence concerns the gene TP53 and breast carcinoma.